[HTML][HTML] Protein kinase CK2: a potential therapeutic target for diverse human diseases

C Borgo, C D'Amore, S Sarno, M Salvi… - Signal transduction and …, 2021 - nature.com
CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of
substrates, controls several signaling pathways, and is implicated in a plethora of human …

[HTML][HTML] Exploring vitamin D metabolism and function in cancer

SM Jeon, EA Shin - Experimental & molecular medicine, 2018 - nature.com
Vitamin D, traditionally known as an essential nutrient, is a precursor of a potent steroid
hormone that regulates a broad spectrum of physiological processes. In addition to its …

[HTML][HTML] Hypoxia and selective autophagy in cancer development and therapy

I Daskalaki, I Gkikas, N Tavernarakis - Frontiers in cell and …, 2018 - frontiersin.org
Low oxygen availability, a condition known as hypoxia, is a common feature of various
pathologies including stroke, ischemic heart disease, and cancer. Hypoxia adaptation …

Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the …

F Pierre, PC Chua, SE O'Brien… - Journal of medicinal …, 2011 - ACS Publications
Herein we chronicle the discovery of CX-4945 (25n), a first-in-class, orally bioavailable ATP-
competitive inhibitor of protein kinase CK2 in clinical trials for cancer. CK2 has long been …

[HTML][HTML] Role of protein kinase CK2 in antitumor drug resistance

C Borgo, M Ruzzene - Journal of Experimental & Clinical Cancer …, 2019 - Springer
Drug resistance represents the major reason of pharmacological treatment failure. It is
supported by a broad spectrum of mechanisms, whose molecular bases have been …

[HTML][HTML] Mining CK2 in cancer

CE Ortega, Y Seidner, I Dominguez - Plos one, 2014 - journals.plos.org
Cancer is a leading cause of death worldwide. Cancer cells proliferate uncontrollably and,
many cases, spread to other parts of the body. A protein historically involved in cancer is …

[HTML][HTML] Targeting CK2 in cancer: a valuable strategy or a waste of time?

M Salvi, C Borgo, LA Pinna, M Ruzzene - Cell Death Discovery, 2021 - nature.com
CK2 is a protein kinase involved in several human diseases (ranging from neurological and
cardiovascular diseases to autoimmune disorders, diabetes, and infections, including …

[HTML][HTML] Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors

M Reinecke, P Brear, L Vornholz, BT Berger… - Nature Chemical …, 2023 - nature.com
Medicinal chemistry has discovered thousands of potent protein and lipid kinase inhibitors.
These may be developed into therapeutic drugs or chemical probes to study kinase biology …

[HTML][HTML] Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy–potential clinical relevance

C D'Amore, C Borgo, S Sarno, M Salvi - Cellular Oncology, 2020 - Springer
Background Protein kinase CK2 inhibition has long been considered as an attractive anti-
cancer strategy based on the following considerations: CK2 is a pro-survival kinase, it is …

[HTML][HTML] Protein kinase CK2–diverse roles in cancer cell biology and therapeutic promise

JH Trembley, BT Kren, M Afzal, GA Scaria… - Molecular and cellular …, 2023 - Springer
The association of protein kinase CK2 (formerly casein kinase II or 2) with cell growth and
proliferation in cells was apparent at early stages of its investigation. A cancer-specific role …